NCT00168311View on ClinicalTrials.gov

A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Schizophrenia
Interventions
DEVICE

Transcranial Magnetic Stimulation

Participants were sequentially randomly assigned to either 15 active bilateral treatments or 15 sham bilateral treatments that were administered on a daily basis, five days per week.

DEVICE

sham TMS

Trial Locations (1)

3181

Alfred Psychiatry Research Centre, Melbourne

All Listed Sponsors
lead

The Alfred

OTHER

NCT00168311 - A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia | Biotech Hunter | Biotech Hunter